- Hepatocellular Carcinoma Treatment and Prognosis
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gallbladder and Bile Duct Disorders
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Pancreatitis Pathology and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
- Organ Transplantation Techniques and Outcomes
- Religious and Theological Studies
- MRI in cancer diagnosis
- Multiple and Secondary Primary Cancers
- Neuroendocrine Tumor Research Advances
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Pediatric Hepatobiliary Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Liver physiology and pathology
- Cancer Genomics and Diagnostics
- Radiation Dose and Imaging
- COVID-19 and healthcare impacts
- Metastasis and carcinoma case studies
A. O. Ordine Mauriziano di Torino
2015-2025
University of Bologna
2023
Policlinico Umberto I
2023
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2023
Ospedale Garibaldi
2014-2022
Ospedali Riuniti Umberto I
2009-2021
Hôpitaux Universitaires de Strasbourg
2013-2016
Université de Strasbourg
2013-2016
Ospedale Santa Maria di Loreto Nuovo
2005-2007
Abstract Bile duct injury (BDI) is a dangerous complication of cholecystectomy, with significant postoperative sequelae for the patient in terms morbidity, mortality, and long-term quality life. BDIs have an estimated incidence 0.4–1.5%, but considering number cholecystectomies performed worldwide, mostly by laparoscopy, surgeons must be prepared to manage this surgical challenge. Most are recognized either during procedure or immediate period. However, some may discovered later period,...
To determine which method of liver volumetry is more accurate in predicting a safe resection.Before major or extended hepatectomy, assessment the future remnant (FLR) crucial to reduce risk postoperative hepatic insufficiency. The FLR volume usually expressed as ratio nontumorous total (TLV), can be measured directly by computed tomography (mTLV) estimated (eTLV) on basis correlation existing with body surface area. date, these 2 methods have never been compared.All consecutive, noncirrhotic...
Standard imaging cannot assess the pathology details of intrahepatic cholangiocarcinoma (ICC). We investigated whether CT-based radiomics may improve prediction tumor characteristics. All consecutive patients undergoing liver resection for ICC (2009-2019) in six high-volume centers were evaluated inclusion. On preoperative CT, we segmented (Tumor-VOI, i.e., volume-of-interest) and a 5-mm parenchyma rim around (Margin-VOI). considered two types data: grading (G) microvascular invasion (MVI)....
Abstract Background Surgical resection (SR) is a potentially curative treatment of hepatocellular carcinoma (HCC) hampered by high rates recurrence. New drugs are tested in the adjuvant setting, but standardised risk stratification tools HCC recurrence lacking. Objectives To develop and validate simple scoring system to predict 2‐year after SR for HCC. Methods 2359 treatment‐naïve patients who underwent 17 centres Europe Asia between 2004 2017 were divided into development (DS; n = 1558)...
Traditional approach to incisional hernias (IHs) in cirrhotic patients is plagued by a significant recurrence rate and frequent wound infections. The laparoscopic repair of IHs was designed offer minimally invasive tension-free technique that yields less morbidity fewer recurrences than the standard open repair. In there are additional reasons for benefits laparoscopy. First, preservation abdominal wall avoids interruption large collateral veins. Second, nonexposure viscera restricts...
Background . To assess the efficacy of intraoperative ultrasound (IOUS) compared with liver-specific magnetic resonance imaging (MRI) in patients colorectal liver metastases (CRLMs). Methods From January 2010 to December 2017, 721 underwent MRI as a part preoperative workup within 1 month before hepatectomy and were considered for study. Early intrahepatic recurrence (relapse at cut surface excluded) was assessed 6 months after resection residual disease undetected by IOUS and/or MRI....
Despite the worldwide increase of both obesity and use minimally invasive liver surgery (MILS), evidence regarding safety eventual benefits MILS in obese patients is scarce. The aim this study was therefore to compare outcomes non-obese (BMI 18.5-29.9 BMI≥30, respectively) undergoing OLS, assess trends among patients.In retrospective cohort study, operated at 20 hospitals eight countries (2009-2019) were included characteristics compared. Thereafter, OLS compared groups after...